
Karan graduated from Babson University with a Masters of Business Administration (MBA) and joined Kemwell in May 2011. At Kemwell, Karan led the effort to acquire Cirrus Pharmaceuticals Inc. USA and manages corporate activities including Finance and Business Development. Before joining Kemwell, he worked as a financial analyst for the Bioscience Division at Millipore USA, where he assisted the international operations with finance reporting and was involved in analyzing two potential acquisitions. In 2007, he was instrumental in the Bagaria Family divestiture of their stake in Millipore India.